Overview of the Requirements on WFI in the EU, USA and Japan

Recommendation
14-16 October 2025
GMP Compliance and Technology for the Manufacture of Oral Solid Dosage Forms
Again and again, the question arises about the limits laid down in the different GMP regulations and Pharmacopoeias and what procedures are applicable to the manufacture of water for injection (WFI). The table below gives you an overview of the current requirements on the production as well as on certain testing elements. It is remarkable to notice that only EU authorities are against the inclusion of membrane procedures for the production of WFI.
| USP | EP | JP |
Production of WFI | Distillation or purification process proven to be equivalent or superior to distillation | Distillation only | Distillation or RO/UF |
Conductivity [µS/cm at 25 °C or equivalent at other temperatures] | 1.3 | 1.3 | 1.3 |
TOC [ppb] | ≤ 500 | ≤500 | ≤ 500 |
Endotoxin | 0.25 EU/mL | 0.25 EU/mL | 0.25 EU/mL |
Bacteria [cfu/100 mL] | 10 | 10 | 10 |
Nitrates [ppm] | N/A | 0.2 | N/A |
Ammonium [mg/L] | N/A | N/A | N/A |
Related GMP News
17.09.2025What Water Quality Is Required for Air Humidification in GMP Cleanrooms?
27.08.2025Insufficient Weight Uniformity in Tableting
27.08.2025Warning Letter to Indian API Manufacturer: Batch Release After Fire Incident
30.07.2025EDQM publishes three revised Texts on Pharmaceutical Water
30.07.2025US Manufacturer buys ‘Pharmaceutical Water’ in Grocery Store
30.07.2025VDI updates Cleanroom Guidelines 2083 Sheets 4.1 and 4.2